CRYPTOCOCCOSIS IN A RENAL UNIT

被引:15
作者
KONG, NCT
SHAARIAH, W
MORAD, Z
SULEIMAN, AB
WONG, YH
机构
[1] GEN HOSP, DEPT NEPHROL, KUALA LUMPUR, MALAYSIA
[2] GEN HOSP, DIV MICROBIOL, KUALA LUMPUR, MALAYSIA
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1990年 / 20卷 / 05期
关键词
Cryptococcal antigen titre; Cryptococcosis; post renal transplant; SLE;
D O I
10.1111/j.1445-5994.1990.tb00393.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cryptococcosis is a known opportunistic infection in immunosuppressed hosts. We report our experience of all cases presenting to our Department between December 1975 and September 1988. Eight post‐renal transplant patients and three systemic lupus erythematosus (SLE) patients were affected. All were receiving treatment with steroids, in association with either azathioprine or cyclosporin. The diagnosis of cryptococcal meningitis was initially based on a positive cerebrospinal fluid (CSF) cryptococcal antigen, by latex agglutination test, and subsequently confirmed by cultures. Common clinical presentations, in descending order of frequency, included headaches, fever, mental confusion, epilepsy and papilloedema. Meningism was not a prominent feature. CT brain scans were obtained in eight patients and one showed a focal lesion and one showed cerebral atrophy. Four patients also had an abnormal chest X‐ray (CXR) and one had disseminated cryptococcosis. Amphotericin and 5‐fluorocytosine were the mainstay of therapy, although ketoconazole alone was subsequently used in three selected patients with cure. Four early deaths occurred in patients with delayed diagnosis and treatment, usually in association with other severe concurrent infections. We conclude that awareness of cryptococcosis is essential in immunocompromised hosts presenting with headaches with, or without, mental confusion or fever. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:645 / 649
页数:5
相关论文
共 16 条
[1]   COMPARISON OF AMPHOTERICIN-B ALONE AND COMBINED WITH FLUCYTOSINE IN THE TREATMENT OF CRYPTOCCAL MENINGITIS [J].
BENNETT, JE ;
DISMUKES, WE ;
DUMA, RJ ;
MEDOFF, G ;
SANDE, MA ;
GALLIS, H ;
LEONARD, J ;
FIELDS, BT ;
BRADSHAW, M ;
HAYWOOD, H ;
MCGEE, ZA ;
CATE, TR ;
COBBS, CG ;
WARNER, JF ;
ALLING, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (03) :126-131
[2]  
DEWYTT CN, 1982, J NEUROL SCI, V53, P282
[3]   PROGNOSTIC FACTORS IN CRYPTOCOCCAL MENINGITIS - STUDY IN 111 CASES [J].
DIAMOND, RD ;
BENNETT, JE .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :176-181
[4]   CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS [J].
DISMUKES, WE .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) :624-628
[5]   PHARMACOKINETIC EVALUATION OF UK-49,858, A METABOLICALLY STABLE TRIAZOLE ANTIFUNGAL DRUG, IN ANIMALS AND HUMANS [J].
HUMPHREY, MJ ;
JEVONS, S ;
TARBIT, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :648-653
[6]  
JOEI LT, 1985, J NEUROL NEUROSUR PS, V48, P853
[7]  
KAPLAN MH, 1977, CANCER, V39, P2265, DOI 10.1002/1097-0142(197705)39:5&lt
[8]  
2265::AID-CNCR2820390546&gt
[9]  
3.0.CO
[10]  
2-X